OESOPHAGEAL WALL HYPERTROPHY

This adverse event was reported 34 times

These drugs are most commonly taken by patients reporting OESOPHAGEAL WALL HYPERTROPHY:

# Drug Count
0 FLUOROURACIL 6
1 FLUOROURACIL CREAM, 0.5% 6
2 PEMBROLIZUMAB 6
3 ACETAMINOPHEN 2
4 ADALIMUMAB 2
5 ATENOLOL 2
6 CISPLATIN 2
7 CLOZAPINE 2
8 DICLOFENAC 2
9 DICLOFENAC SODIUM 2
See all common drugs associated with OESOPHAGEAL WALL HYPERTROPHY

OESOPHAGEAL WALL HYPERTROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TISLELIZUMAB-JSGR 1 0.0045
1 DEXTROMETHORPHAN HYDROBROMIDE, BUPROPION HYDROCHLORIDE 1 0.0003
2 IRINOTECAN HYDROCHLORIDE 2 0.0002
3 BENZTROPINE 1 0.0001
4 PEGVALIASE-PQPZ 1 0.0001
5 DASATINIB 1 0.0001
6 LEUCOVORIN CALCIUM 2 0.0001
7 CEFUROXIME 1 0.0001
8 SODIUM BICARBONATE INJECTION, 2 0.0001
9 CRIZOTINIB 1 0.0001
See all drugs enriched for association with OESOPHAGEAL WALL HYPERTROPHY